妓院一钑片免看黄大片,亚洲av无码成人精品国产,亚洲AV综合色区无码专区桃色,免费A级毛片在线播放不收费

美國BioMimetic
美國仿生治療公司（BioMimetic Therapeutics Inc.)促進(jìn)肌肉骨骼損傷和疾病，包括整形外科，脊柱及運(yùn)動(dòng)損傷的應(yīng)用愈合。仿生開發(fā)的所有產(chǎn)品都是基于重組人血小板衍生生長(zhǎng)因子（rhPDGF- BB）的平臺(tái)技術(shù)，這是一種生長(zhǎng)因子，人體的主要推動(dòng)者和直接刺激愈合和再生一合成形式。

Located in Franklin, Tennessee, BioMimetic is a biotechnology company specializing in the development and commercialization of innovative drug-device combination products to promote the healing of musculoskeletal injuries and diseases, including orthopedic, spine and sports injury applications. All products developed by BioMimetic are based upon recombinant human platelet-derived growth factor (rhPDGF-BB) platform technology, which is a synthetic form of PDGF, one of the body's principal agents to stimulate and direct healing and regeneration. Through the commercialization of this patented technology, BioMimetic seeks to become the leading company in the field of regenerative medicine by providing new treatment options for the repair of bone, cartilage, tendons and ligaments, thus helping patients recover faster from their orthopedic injuries.

While on staff at Harvard beginning in the mid 1980s, Dr. Samuel Lynch, BioMimetic's president, CEO and founder, conducted research on the role of PDGF in tissue repair and regeneration. These efforts generated a foundation of scientific knowledge and intellectual property from which BioMimetic Therapeutics is now based.